Controversies in Gastrointestinal Premalignant and Malignant Disorders - 2020
Apr 3, 2020 7:30 AM
Early recognition and management of premalignant gastrointestinal disorders are important in the prevention and early detection of cancer. With advances in our understanding of the pathogenesis and natural history of premalignant and malignant GI disorders, treatment algorithms continue to evolve. Emerging endoscopic techniques also play an important role in the diagnosis and management of these patients.
This one day course will update the participant on current controversies regarding the diagnosis, management and surveillance of GI premalignant and malignant disorders involving the upper and lower GI tracts, liver and pancreaticobiliary tracts. Topics will include Barrett’s esophagus, gastric intestinal metaplasia, early esophageal cancer, early gastric cancer, hepatocellular carcinoma, pancreas cyst lesions, malignant hilar biliary obstruction, ampullary adenoma, colon cancer screening, fecal immunochemical test (FIT)-DNA stool testing, IBD and dysplasia, large colon polyps, Lynch syndrome chemoprevention, upper GI tract screening in Lynch syndrome, hereditary gastric cancer, and pancreas cancer screening in high-risk populations. The course will utilize didactic lectures as well as clinical case presentations.
MSK CME offers a discounted rate for MSK Alumni, MSK Cancer Alliance and Cancer Care Partners. If you are a member of one of these groups, please contact firstname.lastname@example.org for more information.
Read more and register here